Table 3 Outcome (mortality) in TTS patients
Variables | No catecholamines (n = 93) | catecholamines (n = 21) | Relative risk (95% CI) | p value * |
|---|---|---|---|---|
In-hospital mortality | 3 (3.22) | 6 (28.57) | (1.0–6.5) | < 0.01 |
30-day mortality | 3 (2.15) | 6 (28.57) | (1.0–6.5) | < 0.01 |
1-year mortality | 6 (6.45) | 8 (38.09) | (1.1–3.7) | < 0.01 |
2-year mortality | 11 (11.82) | 10 (47.61) | (1.1–2.5) | < 0.01 |
3-year mortality | 12 (12.90) | 11 (52.38) | (1.1–2.5) | < 0.01 |
4-year mortality | 18 (19.35) | 11 (52.38) | (1.0–1.9) | < 0.01 |
Long-term mortality | 20 (21.50) | 13 (61.90) | (1.1–2.0) | < 0.01 |